BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9447292)

  • 1. Coexistence of an autonomously functioning thyroid nodule in a patient with Graves' disease: an unusual presentation of Marine-Lenhart syndrome.
    Nishikawa M; Yoshimura M; Yoshikawa N; Toyoda N; Yonemoto T; Ogawa Y; Mori S; Tabata S; Tokoro T; Sakaguchi N; Inada M
    Endocr J; 1997 Aug; 44(4):571-4. PubMed ID: 9447292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of Marine-Lenhart syndrome and Graves' ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis.
    Le Moli R; Russo M; Malandrino P; Vella V; Belfiore A; Frasca F
    Hormones (Athens); 2021 Mar; 20(1):161-165. PubMed ID: 32500462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of Graves' disease associated with an autonomously functioning thyroid nodule (AFTN) (Marine-Lenhalt syndrome) which spontaneously became a cold nodule.
    Konno N; Hirokawa J; Abe S
    Endocrinol Jpn; 1988 Oct; 35(5):753-8. PubMed ID: 3220052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An uncommon case of Marine-Lenhart syndrome.
    Giuffrida G; Giovinazzo S; Certo R; Vicchio TM; Baldari S; Campennì A; Ruggeri RM
    Arq Bras Endocrinol Metabol; 2014 Jun; 58(4):398-401. PubMed ID: 24936736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marine-Lenhart syndrome in a young girl.
    Şen Y; Cimbek EA; Yuca SA; Gedik GK; Sarı O
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):189-91. PubMed ID: 24057592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' disease with an autonomously functioning thyroid nodule: case report.
    Jabrocka-Hybel A; Gołkowski F; Bałdys-Waligórska A; Sokołowski G; Hubalewska-Dydejczyk A
    Pol Arch Med Wewn; 2009; 119(7-8):505-8. PubMed ID: 19776692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.
    Arai N; Inaba M; Ichijyo T; Kagami H; Mine Y
    J Med Case Rep; 2017 Jan; 11(1):9. PubMed ID: 28061802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COEXISTENCE OF GRAVES' DISEASE AND TOXIC ADENOMA: A RARE PRESENTATION OF MARINE-LENHART SYNDROME.
    Avci E; Narci H
    J Ayub Med Coll Abbottabad; 2015; 27(1):248-50. PubMed ID: 26182791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marine-Lenhart syndrome with papillary thyroid carcinoma.
    Atmaca H; Çolak R; Yazici ZA; Kefeli M; Tosun FC
    J Res Med Sci; 2015 Apr; 20(4):412-5. PubMed ID: 26110000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Marine-Lenhart syndrome: a case observation upon 18 years].
    Waldherr C; Otte A; Haldemann A; Müller-Brand J
    Nuklearmedizin; 1999; 38(8):345-8. PubMed ID: 10615671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient with an autonomously functioning thyroid nodule with papillary adenocarcinoma associated with Graves' hyperthyroidism.
    Tsuboi M; Shigemasa C; Ueta Y; Yoshida A; Kobayashi K; Mori T; Mashiba H
    Clin Nucl Med; 1995 Nov; 20(11):985-8. PubMed ID: 8565381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T3-release from autonomously functioning thyroid nodules in vitro.
    Poertl S; Kirner J; Saller B; Mann K; Hoermann R
    Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A remarkable case of thyrotoxicosis initially caused by graves' disease followed by a probable TSHoma - a case report.
    Quinn M; Bashari W; Smith D; Gurnell M; Agha A
    BMC Endocr Disord; 2020 Aug; 20(1):133. PubMed ID: 32854689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a solitary toxic thyroid nodule following Graves' disease.
    Ikekubo K; Hino M; Ito H; Otani M; Shimozato S; Nasu K; Habuchi Y; Yamaguchi H; Saiki Y; Ishihara T
    Clin Nucl Med; 1988 Oct; 13(10):748-50. PubMed ID: 2846224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of simultaneous occurrence of Marine - Lenhart syndrome and a papillary thyroid microcarcinoma.
    Scherer T; Wohlschlaeger-Krenn E; Bayerle-Eder M; Passler C; Reiner-Concin A; Krebs M; Gessl A
    BMC Endocr Disord; 2013 May; 13():16. PubMed ID: 23657056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease triggered by autoinfarction of an autonomously functioning thyroid adenoma.
    Gallegos E; Meier DA; Garcia M
    J Nucl Med; 1997 Feb; 38(2):260-2. PubMed ID: 9025752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Marine-Lenhart syndrome on
    Agrawal K; Patro PSS; Meher BR; Gnanasegaran G
    World J Nucl Med; 2021; 20(4):369-373. PubMed ID: 35018152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
    Valenti TM; Macchia E; Pisa R; Bucalo ML; Russo V; Colletti I; Compagno V; Abbadi V; Donatelli M
    J Endocrinol Invest; 1999 Oct; 22(9):701-4. PubMed ID: 10595835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity and dissimilarity between clinical and laboratory findings, especially anti-thyrotropin receptor antibody in ophthalmic Graves' disease without persistent hyperthyroidism and hyperthyroid Graves' disease.
    Kosugi S; Inoue D; Sugawa H; Enomoto T; Mori T; Imura H
    Endocrinol Jpn; 1990 Jun; 37(3):343-54. PubMed ID: 2253584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.